Chenguang Biotechnology: Announcement on the progress of the subsidiary's repayment of bank loans and provision of guarantees for the subsidiary
Securities code: 300138 Securities abbreviation: Chenguang Biotechnology Announcement number: 2025-110
Chenguang Biotechnology Group Co., Ltd.
Announcement on the progress of the subsidiary's repayment of bank loans and provision of guarantees for the subsidiary
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Chenguang Biotechnology Group Co., Ltd. (hereinafter referred to as the "Company") has changed its bank loan guarantees for its subsidiaries within the scope of the consolidated statements due to business progress. It is hereby announced as follows:
1. Basic situation and progress of external guarantees
- Based on its own operating liquidity needs, as resolved by the company's 2023 annual shareholders' meeting, Chenguang Biotechnology Group Tumushuke Co., Ltd. (hereinafter referred to as "Tumushuke Chenguang", a wholly-owned subsidiary of Xinjiang Chenguang Biotechnology Co., Ltd., and the company's holding subsidiary after penetration) has previously processed two transactions totaling 21,600 with the Kashgar Branch of the Export-Import Bank of China (hereinafter referred to as the "Export-Import Bank") Working capital loan of 10,000 yuan, guarantee method: company guarantee guarantee (the company and the Export-Import Bank of China signed a "Guarantee Contract" for the above two loans respectively. The guarantee scope is: 1. Loan principal: 108 million yuan, 2. Interest, liquidated damages, damages, costs of realizing creditor's rights, etc.; the guarantee method is: joint liability guarantee; the guarantee period is: three years from the expiration date of the debt performance period under the main contract. For details, see November 2024 The "Announcement on the Progress of Providing Guarantees for Bank Loans of Subsidiaries" was disclosed on cninfo.com on March 1).
In the early stage, Tumushuke Chenguang has repaid and settled one of the loans of 108 million yuan (for details, please see the "Announcement on the Progress of the Subsidiary's Return of Bank Loans and the Provision of Guarantees for the Subsidiary" disclosed on cninfo.com on September 11, 2025). Recently, Tumushuke Chenguang repaid the remaining 108 million yuan loan from the Export-Import Bank of China, and the company reduced the corresponding guarantee obligation of 108 million yuan.
- Based on its own operating liquidity needs, as resolved by the company's 2023 annual shareholders' meeting, Kashgar Chenguang Vegetable Protein Co., Ltd. (hereinafter referred to as "Kashgar Protein", the above-mentioned company is a wholly-owned subsidiary of Xinjiang Chenguang, and after penetration is the company's holding subsidiary) applied to the Korla Branch of Kunlun Bank Co., Ltd. (hereinafter referred to as "Kunlun Bank") for 3,000 Ten thousand yuan of working capital loan, the guarantee method is: company guarantee guarantee (the company signed a "Guarantee Contract" with Kunlun Bank, the guarantee amount is: 30 million yuan; the guarantee method is: joint liability guarantee; the guarantee period is: three years from the day after the expiration of each debt loan period under the independent contract; the guarantee scope is: the principal creditor's principal, interest, compound interest, penalty interest, liquidated damages, damages, exchange rate losses and costs of realizing the creditor's rights. See November 2024 for details The "Announcement on the Progress of Providing Guarantees for Bank Loans of Subsidiaries" was disclosed on cninfo.com on March 6).
As of the announcement date, Kashgar Protein has repaid the above-mentioned 30 million yuan loan from Kunlun Bank, and the company has reduced the corresponding guarantee obligation of 30 million yuan.
- Based on its own operating liquidity needs, as resolved by the company's 2023 annual shareholders' meeting, Tumushuke Chenguang applied for a working capital loan of 10 million yuan from the Urumqi Branch of China Everbright Bank Co., Ltd. (hereinafter referred to as "Ebright Bank") in the early stage. The guarantee method was: its parent company Xinjiang Chenguang Guarantee (Xinjiang Chenguang and Everbright Bank signed a "Guarantee Contract" for the above-mentioned loan, and the principal guaranteed creditor's right is 1,000 Ten thousand yuan, the scope of the guarantee is: loan principal, interest, compound interest, liquidated damages, damages, expenses for realizing creditor's rights and all other expenses payable; the guarantee method is: joint liability guarantee; the guarantee period is: three years from the expiration date of the debt performance period under the main contract. For details, please refer to the "Progress Announcement on Providing Guarantee for Subsidiary Bank Loans" disclosed on cninfo.com on March 19, 2025).
As of the announcement date, Tumushuke Chenguang has repaid the above-mentioned 10 million yuan loan from China Everbright Bank, and the company has reduced its corresponding guarantee obligation of 10 million yuan.
2. Cumulative external guarantees
After the changes in the above guarantee situation, the company and its subsidiaries cumulatively resolved to provide a total financing guarantee of RMB 2.50 million to entities within the scope of the consolidated statements, accounting for 80.40% of the company's most recent audited net assets, of which: the guaranteed amount of signed agreements was RMB 1,281.25 million (before this change in the guarantee situation, the balance of the guaranteed guarantees in signed agreements was RMB 1,429.25 million).
Among them: it was decided to provide a total guarantee of RMB 2.05 billion for the subsidiary Xinjiang Chenguang Biotechnology Co., Ltd. and its subsidiaries within the scope of the consolidated statements (including mutual guarantees by all entities within the scope of Xinjiang Chenguang's consolidated statements), and the guaranteed amount of the signed agreement was RMB 1.18125 million (before this change in the guarantee situation, the balance of the guaranteed guarantee under the signed agreement was RMB 1.32925 million).
The company and its subsidiaries have no overdue external guarantees.
Announcement hereby
Board of Directors of Chenguang Biotechnology Group Co., Ltd.
October 14, 2025